Positron Emission Tomography Devices

Positron Emission Tomography Devices Market Outlook

The global Positron Emission Tomography (PET) devices market is expected to reach approximately USD 5.8 billion by 2035, growing at a robust Compound Annual Growth Rate (CAGR) of around 7.4% during the forecast period from 2025 to 2035. The increasing prevalence of cancer and cardiovascular diseases, along with the growing demand for early diagnostic imaging, are key factors driving this market's growth. Additionally, technological advancements in imaging modalities, coupled with rising healthcare expenditure and favorable reimbursement policies, serve as significant growth catalysts. The wave of innovations such as hybrid imaging techniques like PET-CT and PET-MR is further propelling the market forward, making PET devices more efficient and effective in diagnosing various ailments.

Growth Factor of the Market

The Positron Emission Tomography (PET) devices market is experiencing substantial growth driven by various factors, chief among them being the rising incidence of diseases such as cancer and neurological disorders, which necessitate advanced diagnostic tools. Furthermore, the integration of PET imaging with other modalities such as CT and MRI is enhancing diagnostic accuracy, thereby encouraging healthcare providers to adopt these technologies. Increasing investments in healthcare infrastructure, especially in emerging economies, are also fueling the demand for sophisticated imaging equipment. The aging population is another demographic factor contributing to market expansion, as older adults are more prone to the aforementioned health issues, leading to a higher demand for diagnostic imaging. Additionally, enhanced public awareness surrounding early disease detection and the role of PET in personalized medicine are creating further opportunities for market growth.

Key Highlights of the Market

• The global PET devices market is projected to reach approximately USD 5.8 billion by 2035.
• Technological advancements, including hybrid imaging systems, are transforming diagnostic capabilities.
• Oncology remains the leading application area, accounting for a significant share of the market.
• North America is expected to dominate the market due to advanced healthcare infrastructure and high healthcare spending.
• Emerging markets in Asia Pacific are anticipated to witness rapid growth due to increasing healthcare investments.

By Product Type

Full Ring PET Scanners:

Full ring PET scanners represent a significant segment of the PET devices market, primarily due to their high sensitivity and resolution capabilities. These scanners are designed with detectors arranged in a complete ring, enabling them to capture comprehensive 3D images of the body. The advantages of full ring PET scanners include faster scanning times and improved image quality, which are essential for accurate diagnosis and treatment planning in oncology and other medical fields. Furthermore, advancements in detector technologies and software algorithms continue to enhance the performance of full ring scanners, making them increasingly vital in clinical settings. Their ability to support various imaging protocols and integrate seamlessly with other imaging modalities also contributes to their sustained demand among healthcare providers, fostering market growth.

Partial Ring PET Scanners:

Partial ring PET scanners are increasingly gaining traction in the market due to their ability to offer a more compact design while still delivering satisfactory imaging capabilities. These scanners are often more cost-effective than their full ring counterparts, making them attractive options for smaller healthcare facilities and diagnostic centers. While they may not match the sensitivity and resolution of full ring scanners, advancements in technology have enabled partial ring PET scanners to provide adequate imaging for routine diagnostics. These devices are particularly beneficial in settings with space constraints or limited budgets, thus expanding their adoption. The versatility in application across various medical fields, including cardiology and neurology, further adds to their appeal in the healthcare sector.

Desktop PET Scanners:

Desktop PET scanners are emerging as a niche segment in the PET devices market, primarily designed for smaller facilities and specialized applications. These compact systems are ideal for research and development purposes and are increasingly utilized in preclinical studies. Their portability and ease of use make them attractive for academic institutions and laboratories focused on innovative research in molecular imaging. Although they may have limitations in terms of imaging volume compared to larger systems, desktop PET scanners provide a cost-effective solution for institutions looking to explore PET technology without substantial investment. As the demand for personalized medicine and targeted therapies grows, the role of desktop PET scanners in advancing research and education is likely to expand, creating new opportunities for market players.

Handheld PET Scanners:

Handheld PET scanners are groundbreaking advancements in the field of imaging, offering remarkable portability and user-friendliness. Though still in the early stages of adoption, these devices are tailored for point-of-care applications, enabling rapid imaging for emergencies and remote locations. The convenience of handheld devices allows healthcare professionals to perform PET imaging in diverse environments outside traditional settings, enhancing accessibility to diagnostic imaging. As technology continues to progress, it's anticipated that handheld PET scanners will evolve to offer better resolution and sensitivity, potentially transforming how certain conditions are diagnosed and monitored. The growing trend of mobile healthcare solutions and telemedicine further supports the potential growth of handheld PET devices in the market.

Wearable PET Scanners:

Wearable PET scanners signify a significant innovative leap within the imaging sector, aimed at providing continuous monitoring for patients outside the conventional clinical environments. This technology is particularly appealing for chronic disease management, allowing healthcare providers to track patients' conditions in real-time. The integration of PET imaging with wearable technology can facilitate immediate feedback and prompt medical interventions, thus ensuring a proactive approach to patient care. As healthcare embraces personalized medicine, the demand for innovative solutions like wearable PET scanners is expected to grow. However, challenges related to miniaturization and maintaining image quality remain, necessitating ongoing research and development efforts to maximize their effectiveness and clinical utility.

By Application

Oncology:

Oncology is the most prominent application area for PET devices, owing to the technology's pivotal role in tumor detection, staging, and monitoring treatment response. PET imaging allows for the identification of metabolic activity within tumors, providing critical information that is often not visible through conventional imaging techniques. The increasing incidence of cancer worldwide, coupled with advancements in PET technology, has led to heightened demand in this field. Healthcare professionals rely on PET imaging to make informed decisions regarding treatment plans, with the ability to visualize tumor response to therapies significantly enhancing patient outcomes. As personalized medicine continues to evolve, the role of PET in oncology will likely expand, further solidifying its importance in cancer care.

Cardiology:

Cardiology has increasingly adopted PET imaging as a powerful tool for diagnosing and assessing various cardiovascular conditions. The ability of PET to evaluate myocardial perfusion and viability makes it indispensable in managing patients with coronary artery disease and heart failure. PET imaging offers unparalleled insight into cardiac function, enabling clinicians to pinpoint areas of ischemia and assess the effectiveness of therapeutic interventions. The growing prevalence of cardiovascular diseases globally is propelling the demand for PET devices in this application area, as early detection and treatment are crucial for improving patient outcomes. Moreover, as technology advances, the integration of PET with other imaging modalities is likely to enhance diagnostic accuracy, further driving growth in this segment.

Neurology:

Neurology is another critical application area for PET devices, where the technology is pivotal for diagnosing and monitoring neurological disorders such as Alzheimer's disease, epilepsy, and brain tumors. PET imaging provides insights into cerebral metabolism and blood flow, facilitating early diagnosis and improved management of these conditions. The increasing prevalence of neurodegenerative disorders due to an aging population is driving the demand for PET imaging in neurology. Furthermore, research into novel biomarkers for various neurological diseases is enhancing the role of PET imaging in clinical settings. As advancements continue, PET's contribution to personalized treatment plans for patients with neurological conditions is expected to grow, solidifying its position in this vital application area.

Orthopedics:

In the field of orthopedics, PET imaging is gaining recognition for its ability to assess bone metabolism and detect infections or malignancies in bone tissue. While traditionally not the primary imaging modality for orthopedic conditions, the growing acknowledgment of PET's capabilities in identifying subtle changes in bone activity is spurring its use. PET imaging can provide valuable information on bone remodeling, helping orthopedic surgeons make informed decisions regarding surgeries and therapies. The increasing prevalence of chronic orthopedic conditions and the need for precise diagnostics are driving demand in this area. As further research validates the efficacy of PET imaging in orthopedics, its application is expected to expand, offering an additional tool for healthcare providers.

Others:

The "Others" category encompasses various applications of PET devices in fields such as infectious diseases and rheumatology, where the technology demonstrates potential benefits beyond traditional applications. PET imaging is increasingly being used to evaluate infections, especially in complex cases where conventional imaging fails to provide adequate information. Moreover, its application in rheumatology aids in assessing inflammatory diseases such as rheumatoid arthritis, providing insights into patient management. As the healthcare landscape evolves, the diversification of PET applications is anticipated to grow, fueled by ongoing research and technological advancements. This segment represents opportunities for market expansion as PET imaging finds new roles in diagnosing and assessing conditions across multiple specialties.

By Distribution Channel

Hospitals:

Hospitals are the primary distribution channel for PET devices, driven by their comprehensive diagnostic capabilities and diverse patient populations. These institutions typically have the necessary infrastructure and expertise to operate advanced imaging technologies, making them the preferred setting for PET scanning. With the increasing number of cancer and cardiovascular patients, hospitals are investing in state-of-the-art PET imaging systems to enhance diagnostic accuracy and improve patient outcomes. The growing emphasis on integrated healthcare services also supports the demand for PET devices within hospitals, as they strive to provide holistic and timely care. Additionally, hospitals often benefit from favorable reimbursement policies for PET imaging, further solidifying their position as a leading channel in the distribution of these essential devices.

Diagnostic Centers:

Diagnostic centers play a crucial role in the distribution of PET devices, particularly in providing specialized imaging services to patients. These facilities are often equipped with advanced technologies, including PET scanners, catering to various diagnostic needs in a more accessible setting. The convenience of diagnostic centers, combined with shorter wait times for imaging appointments, appeals to patients seeking timely diagnoses. As the demand for non-invasive imaging techniques rises, diagnostic centers have become integral players in the healthcare ecosystem, often partnering with hospitals to streamline patient referrals. Moreover, the increasing trend of preventive healthcare is driving the growth of diagnostic centers, solidifying their position in the PET devices market.

Research Institutes:

Research institutes are a vital distribution channel for PET devices, particularly due to their focus on innovation and advancements in imaging technology. These institutions often utilize PET scanning for preclinical studies, drug development, and clinical trials, aiming to explore new therapeutic approaches and improve existing methodologies. The collaboration between research institutes and the healthcare industry is fostering advancements in PET imaging, ensuring that new technologies are developed and validated for clinical use. Additionally, the growing emphasis on personalized medicine and molecular imaging is driving research initiatives, thus increasing the demand for PET devices within these settings. As the landscape of medical research evolves, research institutes will continue to play a significant role in the growth of the PET devices market.

Others:

The "Others" category includes various distribution channels such as mobile imaging services and specialty clinics that also utilize PET devices. Mobile imaging services are gaining popularity by offering convenience and accessibility to patients who may have difficulties accessing traditional healthcare facilities. These services can bring state-of-the-art PET imaging to underserved areas, thereby expanding the reach of diagnostic capabilities. Specialty clinics focusing on areas such as oncology or cardiology are also adopting PET technology to enhance their diagnostic offerings. This diversification in distribution channels allows for greater flexibility and responsiveness to patient needs, ultimately contributing to the overall growth of the PET devices market.

By Technology Type

PET-CT:

PET-CT, or Positron Emission Tomography-Computed Tomography, represents a significant advancement in imaging technology by combining the metabolic information from PET with the anatomical detail of CT scans. This integration allows healthcare providers to obtain a comprehensive view of the patient's condition, facilitating more accurate diagnoses and treatment planning. The growth of the PET-CT segment is driven by its widespread acceptance in oncology, where precise tumor localization and characterization are crucial for effective management. With ongoing technological advancements, PET-CT systems are becoming more efficient, offering enhanced image quality and reduced scan times. As the demand for advanced imaging solutions rises, PET-CT is expected to maintain its dominant position in the market.

PET-MR:

PET-MR, combining Positron Emission Tomography with Magnetic Resonance imaging, is gaining traction in the diagnostic imaging market due to its ability to provide detailed anatomical and functional information simultaneously. This hybrid technology is particularly advantageous in diagnosing neurological conditions and cancers, where soft tissue contrast is crucial. The increasing recognition of the benefits of PET-MR in providing comprehensive patient assessments is driving its adoption among healthcare professionals. While the technology is currently more expensive and less prevalent than PET-CT, ongoing enhancements and reductions in operational costs are likely to bolster its market presence. As the healthcare landscape evolves towards more integrated imaging solutions, PET-MR is poised for continued growth.

Standalone PET:

Standalone PET systems remain relevant in the PET devices market, especially in settings where dedicated imaging for specific conditions is required. These systems are designed solely for PET imaging, providing high-quality metabolic images and facilitating targeted diagnostics. Standalone PET devices are often favored in research settings, where their simplicity and focused capabilities allow for controlled studies and advanced research applications. The demand for standalone PET devices is supported by ongoing research and clinical trials aimed at fine-tuning diagnostic methodologies and developing novel radiopharmaceuticals. As the healthcare industry continues to prioritize advanced imaging techniques, standalone PET systems will find their niche within the broader PET devices market.

By Region

North America is anticipated to dominate the Positron Emission Tomography devices market, with a market share of approximately 40% by 2035. The region's advanced healthcare infrastructure, high rates of healthcare spending, and early adoption of cutting-edge technologies significantly contribute to this dominance. The increasing prevalence of chronic diseases, particularly cancer and cardiovascular conditions, is driving demand for PET imaging in this region. Moreover, the presence of key market players and robust research and development initiatives further bolster the growth of the PET devices market in North America. The projected CAGR for North America during the forecast period is around 7.1%, reflecting the region's sustained investment in advanced imaging technologies.

Europe is the second-largest market for PET devices, accounting for approximately 30% of the global market share in 2035. The increasing focus on personalized medicine and technological advancements in the region are driving the growth of PET imaging applications across various medical specialties. Countries like Germany, the UK, and France are leading in terms of market penetration, fueled by government initiatives promoting advanced diagnostic imaging. The region is also witnessing a growing number of collaborations between healthcare institutions and technology providers, enhancing the development and adoption of innovative PET solutions. With a projected CAGR of around 6.8%, Europe continues to be a pivotal player in the PET devices market.

Opportunities

The Positron Emission Tomography devices market presents numerous opportunities driven by technological advancements and emerging market trends. As healthcare providers increasingly recognize the value of early detection and precise diagnosis, the demand for advanced imaging technologies is expected to surge. Innovations in PET imaging, such as the development of more efficient radiotracers and the integration of artificial intelligence for image interpretation, are set to transform the landscape of diagnostic imaging. Additionally, the growing prevalence of chronic diseases, including cancer and neurological disorders, is fueling the need for effective imaging solutions. As healthcare systems in emerging economies continue to expand, the introduction of cost-effective PET devices will create vast opportunities for market players, enhancing accessibility to diagnostic imaging in underserved regions.

Moreover, the rise of personalized medicine is opening new avenues for the PET devices market. As healthcare moves towards tailored treatment plans, the ability of PET imaging to provide valuable insights into metabolic activity and disease progression will be increasingly sought after. The integration of PET imaging into clinical workflows, especially in oncology and cardiology, presents significant opportunities for growth. Partnerships between technology providers and healthcare institutions will facilitate the development and deployment of innovative PET solutions, fostering a collaborative ecosystem. Additionally, ongoing research into novel applications of PET imaging in various medical fields will further expand its market potential, enabling the technology to play a central role in the future of healthcare.

Threats

The Positron Emission Tomography devices market faces several threats that could potentially hinder its growth. One of the primary concerns is the high cost associated with the acquisition and maintenance of PET imaging systems. The substantial financial investment required can pose significant challenges for smaller healthcare facilities and diagnostic centers, leading to limited access to advanced imaging technologies in certain regions. Additionally, the complex regulatory environment surrounding medical devices can result in delays in approval for new technologies, stifling innovation and market entry for emerging players. The competition from alternative imaging modalities, such as MRI and CT, which may offer lower operational costs and wider availability, could also threaten the growth of the PET devices market. These factors necessitate strategic planning and adaptability among market players to navigate these challenges effectively.

Another major concern impacting the market is the shortage of trained professionals capable of operating advanced PET imaging systems. As the technology evolves, healthcare facilities may struggle to maintain a workforce equipped with the necessary skills and expertise to interpret PET scans accurately. This gap in training not only affects the quality of patient care but also limits the broader adoption of PET imaging solutions across healthcare systems. Furthermore, the changing landscape of healthcare reimbursement policies could create uncertainties for healthcare providers, potentially discouraging investment in new PET technologies. Addressing these threats will require concerted efforts from stakeholders, including regulatory bodies, educational institutions, and technology providers, to ensure sustainable growth in the PET devices market.

Competitor Outlook

• GE Healthcare
• Siemens Healthineers
• Philips Healthcare
• United Imaging Healthcare
• Toshiba Medical Systems Corporation
• Canon Medical Systems Corporation
• Fujifilm Holdings Corporation
• Mediso Medical Imaging Systems
• Neusoft Medical Systems Co., Ltd.
• Shenzhen Anjian Technology Co., Ltd.
• Hitachi Medical Corporation
• SIEMENS Healthineers
• BrainScan
• Positron Corporation
• Hologic, Inc.

The competitive landscape of the Positron Emission Tomography devices market is characterized by a mix of well-established multinational corporations and emerging technology providers. Major companies such as GE Healthcare, Siemens Healthineers, and Philips Healthcare dominate the market with their extensive portfolios and vast distribution networks. These organizations continually invest in research and development to innovate and improve their PET imaging technologies, establishing themselves as leaders in the market. Their ability to integrate advanced imaging techniques with state-of-the-art software solutions enhances the diagnostic capabilities of PET devices, making them attractive to healthcare providers seeking comprehensive solutions. Furthermore, strategic partnerships and collaborations with academic institutions and research organizations are enhancing their market reach and fostering innovation.

Emerging players, including Neusoft Medical Systems and United Imaging Healthcare, are also gaining traction in the PET devices market by focusing on developing cost-effective and efficient imaging solutions. These companies are capitalizing on the growing demand for accessible diagnostic imaging in both developed and developing markets. Their emphasis on technological advancements, such as developing compact and portable PET scanners, positions them favorably in the competitive landscape. As the market continues to evolve, these emerging players will challenge established companies, driving further innovation and enhancing overall competition in the industry.

Looking ahead, key companies are expected to focus on strategic acquisitions and collaborations to broaden their product offerings and expand their market presence. For instance, partnerships with technology firms specializing in artificial intelligence and software solutions could enhance image analysis capabilities, leading to improved diagnostic accuracy. Companies like Hologic, Inc. and Canon Medical Systems are anticipated to invest in enhancing their portfolio by integrating advanced imaging technologies and radiopharmaceuticals. As the demand for personalized medicine grows, these strategic moves will be crucial in maintaining competitiveness in the ever-evolving PET devices market.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 BrainScan
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 GE Healthcare
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Hologic, Inc.
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Philips Healthcare
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Positron Corporation
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 SIEMENS Healthineers
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Siemens Healthineers
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 United Imaging Healthcare
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Hitachi Medical Corporation
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Fujifilm Holdings Corporation
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Mediso Medical Imaging Systems
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Canon Medical Systems Corporation
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Neusoft Medical Systems Co., Ltd.
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Toshiba Medical Systems Corporation
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Shenzhen Anjian Technology Co., Ltd.
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Positron Emission Tomography Devices Market, By Application
    • 6.1.1 Oncology
    • 6.1.2 Cardiology
    • 6.1.3 Neurology
    • 6.1.4 Orthopedics
    • 6.1.5 Others
  • 6.2 Positron Emission Tomography Devices Market, By Product Type
    • 6.2.1 Full Ring PET Scanners
    • 6.2.2 Partial Ring PET Scanners
    • 6.2.3 Desktop PET Scanners
    • 6.2.4 Handheld PET Scanners
    • 6.2.5 Wearable PET Scanners
  • 6.3 Positron Emission Tomography Devices Market, By Distribution Channel
    • 6.3.1 Hospitals
    • 6.3.2 Diagnostic Centers
    • 6.3.3 Research Institutes
    • 6.3.4 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Positron Emission Tomography Devices Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Positron Emission Tomography Devices market is categorized based on

By Product Type

• Full Ring PET Scanners
• Partial Ring PET Scanners
• Desktop PET Scanners
• Handheld PET Scanners
• Wearable PET Scanners

By Application

• Oncology
• Cardiology
• Neurology
• Orthopedics
• Others

By Distribution Channel

• Hospitals
• Diagnostic Centers
• Research Institutes
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• GE Healthcare
• Siemens Healthineers
• Philips Healthcare
• United Imaging Healthcare
• Toshiba Medical Systems Corporation
• Canon Medical Systems Corporation
• Fujifilm Holdings Corporation
• Mediso Medical Imaging Systems
• Neusoft Medical Systems Co., Ltd.
• Shenzhen Anjian Technology Co., Ltd.
• Hitachi Medical Corporation
• SIEMENS Healthineers
• BrainScan
• Positron Corporation
• Hologic, Inc.